Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33570578.
- Also identified by DOI 10.1001/jamainternmed.2021.0299 and PMC identifier 7879382.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study examines changes in the outpatient retail dispensing frequency of proposed treatments for coronavirus disease 2019 after the March 13, 2020, declaration of a national emergency due to the pandemic.
Medical subject headings
- Anti-Retroviral Agents
- Community Pharmacy Services
- Drug Prescriptions
- COVID-19 Drug Treatment